CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-28 | Zago Wagner M. Chief Scientific Officer | Option exercise | +51,000 | 85,000 | ||
| 2026-07-28 | Zago Wagner M. Chief Scientific Officer | Returned to the company | −51,000 | $8.56 | $437K | 34,000 |
| 2026-07-28 | Zago Wagner M. Chief Scientific Officer | Option exercise · Restricted Stock Units | −51,000 | 0 | ||
| 2026-03-03 | Zago Wagner M. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +190,000 | 190,000 | ||
| 2025-07-28 | Zago Wagner M. Chief Scientific Officer | Grant or award | +85,000 | 85,000 | ||
| 2025-03-05 | Zago Wagner M. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +107,500 | 107,500 | ||
| 2024-02-27 | Zago Wagner M. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2023-08-02 | Zago Wagner M. Chief Scientific Officer | Option exercise 10b5-1 | +4,000 | $12.15 | $49K | 4,000 |
| 2023-08-02 | Zago Wagner M. Chief Scientific Officer | Sale 10b5-1 | −3,771 | $66.98 | $253K | 229 |
| 2023-08-02 | Zago Wagner M. Chief Scientific Officer | Sale 10b5-1 | −229 | $68.07 | $16K | 0 |
| 2023-08-02 | Zago Wagner M. Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 58,000 | ||
| 2023-07-05 | Zago Wagner M. Chief Scientific Officer | Option exercise 10b5-1 | +4,000 | $12.15 | $49K | 4,000 |
| 2023-07-05 | Zago Wagner M. Chief Scientific Officer | Sale 10b5-1 | −2,991 | $67.98 | $203K | 1,009 |
| 2023-07-05 | Zago Wagner M. Chief Scientific Officer | Sale 10b5-1 | −1,009 | $68.69 | $69K | 0 |
| 2023-07-05 | Zago Wagner M. Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 62,000 | ||
| 2023-06-07 | Zago Wagner M. Chief Scientific Officer | Option exercise 10b5-1 | +15,000 | $29.81 | $447K | 15,000 |
| 2023-06-07 | Zago Wagner M. Chief Scientific Officer | Option exercise 10b5-1 | +4,000 | $12.15 | $49K | 19,000 |
| 2023-06-07 | Zago Wagner M. Chief Scientific Officer | Sale 10b5-1 | −2,943 | $70.02 | $206K | 16,057 |
| 2023-06-07 | Zago Wagner M. Chief Scientific Officer | Sale 10b5-1 | −12,004 | $70.99 | $852K | 4,053 |
| 2023-06-07 | Zago Wagner M. Chief Scientific Officer | Sale 10b5-1 | −3,759 | $71.96 | $270K | 294 |
Page 1 of 2 · 24 trades